Opioid dependence, characterized by high relapse rates and substantial social harm, represents a major global public health ...
Three life-science prizes were awarded for advances in gene therapies. Opthalmologists Jean Bennett and Albert Maguire, and ...
Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies for patients with Alzheimer's disease (AD) and related neurodegenerative disorders, today announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results